Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel Treitman
Observed name:
R. Treitman
Institutions:
Rocky Vista University,
University of Colorado Anschutz
Observed institutions:
Rocky Vista University,
University of Colorado Cancer Center,
University of Colorado Anschutz,
University of Colorado Denver
OpenAlex ID:
A5075174701
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions
2023
·
Ajay Major
, Jovian Yu
, et al.
·
Blood Advances
·
43
PDF
Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma
2026
·
Juan Pablo Alderuccio
, Diva Baggio
, et al.
·
Blood
·
7
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis
2025
·
Y. Sawalha
, S. Sarosiek
, et al.
·
Blood Cancer Journal
·
6
PDF
Survival and Therapeutic Outcomes in T-Cell Prolymphocytic Leukemia (T-PLL): A Collaborative Multi-Center Study Cohort
2024
·
Zachary Braunstein
, Eric McLaughlin
, et al.
·
Blood
·
4
Poor Survival Outcomes of Checkpoint Inhibitors for B-Cell Lymphomas Relapsing after or Refractory to CAR T-Cell Therapy: A Real-World Cohort from 15 U.S. Academic Institutions
2022
·
Ajay Major
, Jovian Yu
, et al.
·
Blood
·
3
339 | Outcomes in an International Multicentre Study of 600 Patients With Cns Relapse of Large B Cell Lymphoma: Compartment of Relapse Is Prognostic
2025
·
D. Baggio
, S. Han
, et al.
·
Hematological Oncology
·
1
PDF
Prognostication and Treatment-Related Outcomes in Secondary Central Nervous System Involvement of Large B-Cell Lymphoma (SCNSL): Evidence from a Large International Cohort
2024
·
Juan Pablo Alderuccio
, Jahanzaib Khwaja
, et al.
·
Blood
·
1
Outcomes of Patients with Relapsed/Refractory Lymphoplasmacytic Lymphoma Treated with Venetoclax: A Multicenter Retrospective Analysis
2023
·
Yazeed Sawalha
, Shayna R Sarosiek
, et al.
·
Blood
·
1
A Case Series of Patients With Cutaneous T‐cell Lymphoma Treated With Combination Mogamulizumab and Other Therapies After Single Agent Mogamulizumab
2023
·
R. Treitman
, M. D. Colton
, et al.
·
Hematological Oncology
·
1
PDF
Multimodal Analgesia in Reducing Opioid Use in General Surgery Patients
2026
·
Rachel Treitman
, Evy Loomis-Goltl
, et al.
·
RVU Elevate
Allogeneic Stem Cell Transplant Results in T-cell Prolymphocytic Leukemia (T-PLL): A Collaborative Multi-Center Study Cohort
2026
·
Zachary Braunstein
, Eric McLaughlin
, et al.
·
Transplantation and Cellular Therapy
Allogeneic stem cell transplant results in t-cell prolymphocytic leukemia (T-PLL): A collaborative multi-center study cohort
2025
·
Zachary Braunstein
, Eric McLaughlin
, et al.
·
Blood
PDF
Frontline chemotherapy for CD30+ non-ALCL peripheral T-cell lymphoma a multi-center retrospective analysis
2025
·
Asaad Trabolsi
, Sunwoo Han
, et al.
·
Blood
PDF
Clinical Outcomes of Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinemia (LPL/WM) in the Targeted Therapy Era: A US Multicenter Retrospective Analysis
2024
·
Muhammad Junaid Tariq
, Kristopher Attwood
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
14
Citation count:
67
H-index:
4
I10-index:
1
Year
Topic
Type